Samsara Bio Capital, LLC Portfolio Holdings

Samsara Bio Capital, LLC

  • $173 Million
  • Q3 2024

Samsara Bio Capital, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $173 Million distributed in 42 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Scholar Rock Holding Corp with a value of $54.4M, Arcellx, Inc. with a value of $29.5M, Nkarta, Inc. with a value of $17M, Eliem Therapeutics, Inc. with a value of $13.3M, and Rhythm Pharmaceuticals, Inc. with a value of $9.04M.

Examining the 13F form we can see an decrease of $21.9M in the current position value, from $194M to 173M.

Samsara Bio Capital, LLC is based out at Palo Alto, CA

Below you can find more details about Samsara Bio Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $173 Million
Healthcare: $170 Million

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 42
  • Current Value $173 Million
  • Prior Value $194 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 3 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Samsara Bio Capital, LLC Portfolio

Follow Samsara Bio Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samsara Bio Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email